Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla
2019 · Breast Cancer · 37 citations
https://doi.org/10.1007/s12282-018-00934-3
P
Pengfei Qiu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
761
Citations
16
h-index
23
i10-index
Pengfei Qiu is an academic researcher from Shandong Tumor Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Cancer Diagnosis and Treatment. The author has an h-index of 16, co-authored 70 publications.
ORCID: 0000-0001-8644-1445Papers by this author
worksNeoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data
2023 · BMC Cancer · 17 citations
https://doi.org/10.1186/s12885-023-10515-z
Internal mammary lymph node metastasis in breast cancer patients based on anatomical imaging and functional imaging
2022 · Breast Cancer · 15 citations
https://doi.org/10.1007/s12282-022-01377-7
A Three lncRNA Set: AC009975.1, POTEH-AS1 and AL390243.1 as Nodal Efficacy Biomarker of Neoadjuvant Therapy for HER-2 Positive Breast Cancer
2021 · Frontiers in Oncology · 5 citations
https://doi.org/10.3389/fonc.2021.779140
Identification of biomarkers of shrinkage modes after neoadjuvant therapy in HER-2 positive breast cancer
2025 · International Journal of Surgery · 5 citations
https://doi.org/10.1097/js9.0000000000002349
A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer
2023 · iScience · 4 citations
https://doi.org/10.1016/j.isci.2023.106330
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat